AstraZeneca expects COVID vaccine result by year-end if trials resume

Go back to AstraZeneca expects COVID vaccine result by year-end if trials resume

Pfizer (PFE), BioNTech SE (BNTX) Announce Submission to FDA to Expand Enrollment of Phase Pivotal COVID-19 Trial up to Approx. 44K Participants

September 14, 2020 6:17 AM EDT

Pfizer Inc. (NYSE: PFE) and... More